Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
Glycosaminoglycans (GAGs) are a class of biomolecules expressed virtually on all mammalian cells and usually covalently attached to proteins, forming proteoglycans. They are present not only on the cell surface, but also in the intracellular milieu and extracellular matrix. GAGs interact with multiple ligands, both soluble and insoluble, and modulate an important role in various physiological and pathological processes including cancer, bacterial and viral infections, inflammation, Alzheimer’s disease, and many more. Considering their involvement in multiple diseases, their use in the development of drugs has been of significant interest in both academia and industry. Many GAG-based drugs are being developed with encouraging results in animal models and clinical trials, showcasing their potential for development as therapeutics. In this review, the role GAGs play in both the development and inhibition of cancer and inflammation is presented. Further, advancements in the development of GAGs and their mimetics as anti-cancer and anti-inflammatory agents are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Heparin and heparan sulfate: Structure and function
Rabenstein, D. L. (2002) · Natural Product Reports · doi:10.1039/b100916h · Cited by 870 · cited 1×
“Heparin, the first GAG-based drug, is used as an anticoagulant for the treatment of thrombosis, thrombophlebitis, and embolism [14].”
BackgroundDemystifying Heparan Sulfate–Protein Interactions
Xu, D., & Esko, J. D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035314 · Cited by 805 · cited 2×
“In addition to electrostatic interactions, non-ionic interactions betwee GAGs and their binding part ers are found to dictate the specificity and selectivity of binding [3].”
BackgroundP-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin.
Moore, K. L., Patel, K. D., Bruehl, R. E., Li, F., Johnson, D. A., Lichenstein, H. S., Cummings, R. D., Bainton, D. F., & McEver, R. P. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.4.661 · Cited by 710 · cited 1×
“The PSGL-1-P-selectin interaction enables leukocytes’ adhesion onto the endothelial layer [70].”
BackgroundTheoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.014 · Cited by 680 · cited 1×
“Heparin is synthesized and stored in certain types of mast cells and is co-released with histamine upon inflammatory trigger [74].”
BackgroundRoles of heparan-sulphate glycosaminoglycans in cancer
Sasisekharan, R., Shriver, Z., Venkataraman, G., & Narayanasami, U. (2002) · Nature Reviews Cancer · doi:10.1038/nrc842 · Cited by 621 · cited 1×
“Heparan sulfate proteoglycans (HSPGs) through their core proteins and GAG side chains modulate multiple functions of tumor cells and are involved in tumor growth, invasion, and metastasis [18,19].”
BackgroundGlycosaminoglycans: key players in cancer cell biology and treatment
Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A. D., Pavão, M. S., Tzanakakis, G. N., & Karamanos, N. K. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08529.x · Cited by 554 · cited 2×
“This inherent heterogeneity involved in the biosynthesis of GAGs leads to a particular GAG binding to many different proteins, thus compromising selectivity and leading to side-effects when given as a therapeutic [16,92].”
BackgroundBiosynthesis and function of chondroitin sulfate
Mikami, T., & Kitagawa, H. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.006 · Cited by 502 · cited 1×
“CS/DS is involved in the regulation of critical cellular processes, such as proliferation, apoptosis, migration, adhesion, and invasion [36].”
BackgroundThe role of heparan sulphate in inflammation
Parish, C. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1918 · Cited by 495 · cited 1×
“Upon leukocyte adhesion on the endothelial cells, HS on the surface of endothelial cells binds to L-selectins on leukocyte, leading to leukocyte rolling [71].”
BackgroundAuvinen, P., Tammi, R., Parkkinen, J., Tammi, M., Ågren, U., Johansson, R., Hirvikoski, P., Eskelinen, M., & Kosma, V.-M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64757-8 · Cited by 493 · cited 1×
“Increased levels of HA are found in multiple types of human cancers, including breast [47], lung [48], and ovarian cancer [49].”
BackgroundRole of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation
Strutz, F., Zeisberg, M., Ziyadeh, F. N., Yang, C.-Q., Kalluri, R., Müller, G. A., Neilson, E. G., Renziehausen, A., & Sisic, Z. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00333.x · Cited by 470 · cited 1×
“HS also plays a crucial role in epithelial to mesenchymal transition (EMT) due to its ability to bind to growth factors present in the tumor microenvironment [23].”
BackgroundProteoglycans and Sulfated Glycosaminoglycans
Esko, J. D., Kimata, K., & Lindahl, U. (2009) · Europe PMC (PubMed Central) · doi:10.1101/glycobiology.3e.017 · Cited by 450 · cited 1×
“Based on these features, GAGs can be broadly classified into four different classes (Figure 1): chondroitin sulfate/dermatan sulfate (CS/DS), heparin/heparan sulfate (HS), hyaluronan (HA), and keratan sulfate (KS) [1].”
BackgroundBinding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.
Webb, L. M., Ehrengruber, M. U., Clark-Lewis, I., Baggiolini, M., & Rot, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7158 · Cited by 442 · cited 1×
“The released chemokines, particularly IL-8 (CXCL-8), bind to GAGs at the endothelial surface, leading to chemokine transcytosis [72].”
BackgroundTheocharis, A. D., Skandalis, S. S., Tzanakakis, G. N., & Karamanos, N. K. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07800.x · Cited by 403 · cited 2×
“For example, it is shown to promote tumor growth in hepatocellular carcinoma and melanoma by stimulating Wnt signaling [26], whereas it inhibited tumor growth by inducing apoptosis in breast and ovarian cancers [18].”
BackgroundGötte, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0739rev · Cited by 348 · cited 1×
“Syndecan, a proteoglycan containing HS chains, plays a major role in this migration process [73].”
BackgroundHigh levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.
Anttila, M., Tammi, R., Tammi, M., Syrjänen, K. J., Saarikoski, S., & Kosma, V. (2000) · PubMed · Cited by 327
Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In Vivo
Oschatz, C., Maas, C., Lecher, B., Jansen, T., Björkqvist, J., Tradler, T., Sedlmeier, R., Burfeind, P., Cichon, S., Hammerschmidt, S., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.008 · Cited by 273
Heparan sulfate proteoglycans in invasion and metastasis
Sanderson, R. D. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0241 · Cited by 262 · cited 2×
“Growth factors Mitogenesis, cell migration Fibroblast growth factor [7,8]”
BackgroundAnti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review
Mousavi, S., Moradi, M., Khorshidahmad, T., & Motamedi, M. (2015) · Advances in Pharmacological Sciences · doi:10.1155/2015/507151 · Cited by 258 · cited 1×
“Several non-anticoagulant heparin mimetics were developed thereafter to maintain its anti-inflammatory effect [80].”
BackgroundRitchie, J. P., Ramani, V. C., Ren, Y., Naggi, A., Torri, G., Casu, B., Penco, S., Pisano, C., Carminati, P., Tortoreto, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2476 · Cited by 250 · cited 2×
“Another modified non-anticoagulant heparin, SST0001 or Roneparstat, was developed by Sigma-Tau Pharmaceuticals as a potent heparanase inhibitor [61].”
BackgroundKeratan sulfate, a complex glycosaminoglycan with unique functional capability
Caterson, B., & Melrose, J. (2018) · Glycobiology · doi:10.1093/glycob/cwy003 · Cited by 249 · cited 1×
“KS has been shown to ameliorate the pathological conditions associated with inflammation [85].”
BackgroundHeparin in Inflammation: Potential Therapeutic Applications beyond Anticoagulation
Tyrrell, D. J., Horne, A. P., Holme, K. R., Preuss, J. M. H., & Page, C. P. (1999) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60471-8 · Cited by 245 · cited 1×
“Besides its use as an anticoagulant, heparin demonstrated excellent anti-inflammatory properties in animal models and clinical trials [76].”
BackgroundGMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice
Chang, J., Patton, J. T., Sarkar, A., Ernst, B., Magnani, J. L., & Frenette, P. S. (2010) · Blood · doi:10.1182/blood-2009-12-260513 · Cited by 238 · cited 2×
“has developed a pan-selectin antagonist, I-1070 (Figure 5 ), to treat vascular occlusions in people ith sickle cell disease [108].”
BackgroundBourguignon, L. Y. W., Singleton, P. A., Zhu, H., & Diedrich, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301885200 · Cited by 237
Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis
Liu, D., Shriver, Z., Venkataraman, G., El Shabrawi, Y., & Sasisekharan, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012578299 · Cited by 228 · cited 1×
“Sasisekharan and coworkers utilized the differential substrate specificity of heparinase I (Hep I) and heparinase III (Hep III) to generate different oligosaccharide GAG fragments from the tumor cell surface [66].”
BackgroundPreventing Bronchoconstriction in Exercise-Induced Asthma with Inhaled Heparin
Ahmed, T., Garrigo, J., & Danta, I. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307083290204 · Cited by 218 · cited 1×
“Heparin has been shown to be useful for the treatment of bronchial asthma [77], ulcerative colitis [78], and burns [79].”
BackgroundHeparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy
Sanderson, R. D., Elkin, M., Rapraeger, A. C., Ilan, N., & Vlodavsky, I. (2017) · The FEBS Journal · doi:10.1111/febs.13932 · Cited by 216
Ricciardelli, C., Mayne, K., Sykes, P. J., Raymond, W. A., McCaul, K. A., Marshall, V. R., & Horsfall, D. J. (1998) · PubMed · Cited by 214
Telen, M. J., Wun, T., McCavit, T. L., De Castro, L. M., Krishnamurti, L., Lanzkron, S., Hsu, L. L., Smith, W. R., Rhee, S., Magnani, J. L., et al. (2015) · Blood · doi:10.1182/blood-2014-06-583351 · Cited by 211 · cited 1×
“It was demonstrated to be safe in Phase I clinical trials [109], reduced the time to resolve vascular occlusive events in Phase II [110], and is currently in Phase III clinical trials.”
BackgroundTranscriptional and post‐translational regulation of hyaluronan synthesis
Tammi, R. H., Passi, A. G., Rilla, K., Karousou, E., Vigetti, D., Makkonen, K., & Tammi, M. I. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08070.x · Cited by 211 · cited 1×
“Growth factors and chemokines present in the tumor microenvironment are known to induce HA production [50].”
BackgroundSugahara, K. N., Murai, T., Nishinakamura, H., Kawashima, H., Saya, H., & Miyasaka, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300347200 · Cited by 204 · cited 1×
“Moreover, degradation of HA to smaller oligosaccharides by hyaluronidases is reported to induce cleaving of CD-44 in the tumor microenvironment, leading to tumor progression, as seen in breast, ovarian, glioma, and colon cancers [56,57].”
BackgroundSelectin Blocking Activity of a Fucosylated Chondroitin Sulfate Glycosaminoglycan from Sea Cucumber
Borsig, L., Wang, L., Cavalcante, M. C. M., Cardilo-Reis, L., Ferreira, P. L., Mourąo, P. A. S., Esko, J. D., & Pavąo, M. S. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610560200 · Cited by 187 · cited 1×
“Fucosylated CS (FucCS), isolated from sea cucumber, was found to inhibit tumor metastasis in vivo by blocking P- and L-selectin-mediated events [67].”
BackgroundDeLisser, H. M., Yan, H. C., Newman, P. J., Muller, W. A., Buck, C. A., & Albelda, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82354-7 · Cited by 180 · cited 1×
“Cell adhesion proteins Cell adhesion, inflammation, metastasis Platelet/endothelial cell adhesion molecule-1 [5]”
BackgroundGlycosaminoglycan (GAG) Biosynthesis and GAG-Binding Proteins
Zhang, L. (2010) · Progress in Molecular Biology and Translational Science · doi:10.1016/s1877-1173(10)93001-9 · Cited by 178 · cited 1×
“Although each of these GAGs has a predominant disaccharide component as mentioned above, as a result of the non-template-driven biosynthetic pathway by which they are produced, these disaccharides can be modified at multiple positions by sulfation, acetylation, and/or epimerization, creating a tremendous amount of het…”
BackgroundZhou, H., Roy, S., Cochran, E., Zouaoui, R., Chu, C. L., Duffner, J., Zhao, G., Smith, S., Galcheva-Gargova, Z., Karlgren, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021106 · Cited by 178 · cited 1×
“M402 or necuparanib is another molecule developed as a non-anticoagulant heparin [60].”
BackgroundRicciardelli, C., Brooks, J. H., Suwiwat, S., Sakko, A. J., Mayne, K., Raymond, W. A., Seshadri, R., LeBaron, R. G., & Horsfall, D. J. (2002) · PubMed · Cited by 175
Mundhenke, C., Meyer, K. K., Drew, S. A., & Friedl, A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64362-3 · Cited by 174 · cited 2×
“Abbreviations GAG Glycosaminoglycan HA Hyaluronan CS Chondroitin sulfate DS Dermatan sulfate HS Heparan sulfate KS Keratan sulfate HSPG Heparan sulfate proteoglycan FGF2 Fibroblast growth factor 2 EMT Epithelial to mesenchymal transition FGFR-1 Fibroblast growth factor receptor-1 EGFR Epidermal growth factor receptor…”
BackgroundTherapeutic Applications of Glycosaminoglycans
Volpi, N. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777452470 · Cited by 163 · cited 1×
“Understanding the type of interaction and the role these GAGs play in multiple cancer types has led to the development of various therapeutic approaches and novel drugs to treat cancer [17].”
BackgroundDredge, K., Hammond, E., Handley, P., Gonda, T. J., Smith, M. T., Vincent, C., Brandt, R., Ferro, V, & Bytheway, I. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.11 · Cited by 162
Proteolytic Cleavage of the CD44 Adhesion Molecule in Multiple Human Tumors
Okamoto, I., Tsuiki, H., Kenyon, L. C., Godwin, A. K., Emlet, D. R., Holgado-Madruga, M., Lanham, I. S., Joynes, C. J., Vo, K. T., Guha, A., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64863-8 · Cited by 160 · cited 1×
“Moreover, degradation of HA to smaller oligosaccharides by hyaluronidases is reported to induce cleaving of CD-44 in the tumor microenvironment, leading to tumor progression, as seen in breast, ovarian, glioma, and colon cancers [56,57].”
BackgroundSulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis
Lemjabbar‐Alaoui, H., van Zante, A., Singer, M. S., Xue, Q., Wang, Y. Q., Tsay, D., He, B., Jablons, D. M., & Rosen, S. D. (2009) · Oncogene · doi:10.1038/onc.2009.365 · Cited by 153 · cited 1×
“Conversely, in the case of lung cancer, it is shown to promote carcinogenesis [35].”
BackgroundPirinen, R., Tammi, R., Tammi, M., Hirvikoski, P., Parkkinen, J. J., Johansson, R., B�hm, J., Hollm�n, S., & Kosma, V.-M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010120)95:1<12::aid-ijc1002>3.0.co;2-e · Cited by 147 · cited 1×
“Increased levels of HA are found in multiple types of human cancers, including breast [47], lung [48], and ovarian cancer [49].”
BackgroundOpposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression
Vlodavsky, I., Gross-Cohen, M., Weissmann, M., Ilan, N., & Sanderson, R. D. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.10.007 · Cited by 137 · cited 1×
“On the contrary, heparanse-2 inhibits the activity of HPSE, thereby acting as a tumor suppressor [32].”
Backgroundten Dam, G. B., van de Westerlo, E. M. A., Purushothaman, A., Stan, R. V., Bulten, J., Sweep, F. C. G. J., Massuger, L. F. A. G., Sugahara, K., & Kuppevelt, T. H. V. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070111 · Cited by 127
Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo
Zittermann, S. I., Capurro, M., Shi, W., & Filmus, J. (2010) · International Journal of Cancer · doi:10.1002/ijc.24941 · Cited by 120 · cited 1×
“For example, it is shown to promote tumor growth in hepatocellular carcinoma and melanoma by stimulating Wnt signaling [26], whereas it inhibited tumor growth by inducing apoptosis in breast and ovarian cancers [18].”
BackgroundRamani, V. C., Yang, Y., Ren, Y., Nan, L., & Sanderson, R. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.183277 · Cited by 115 · cited 1×
“It further stimulates an increase in the expression of both hepatocyte growth factor and syndecan-1, resulting in an aggressive phenotype [31].”
BackgroundDredge, K. S., Hammond, E., Davis, K., Li, C. P., Liu, L., Johnstone, K., Handley, P., Wimmer, N., Gonda, T. J., Gautam, A. M., et al. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9245-5 · Cited by 113 · cited 1×
“Among these analogs, PG545 or pixatimod (Figure 3B) was selected as the lead compound [99].”
MethodHeparin Characterization: Challenges and Solutions
Jones, C. J., Béni, S., Limtiaco, J. F. K., Langeslay, D. J., & Larive, C. K. (2011) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-061010-113911 · Cited by 111 · cited 1×
“The heterogeneity of GAGs makes the complete characterization of every batch of heparin produced nearly impossible, thereby making quality control a daunting task [94].”
BackgroundKarjalainen, J. M., Tammi, R., Tammi, M., Eskelinen, M. J., Ågren, U. M., Parkkinen, J. J., Alhava, E. M., & Kosma, V.-M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64608-1 · Cited by 108 · cited 1×
“On the other hand, low levels of HA are associated with metastatic potential in squamous cell carcinoma [51] and melanoma [52].”
BackgroundYang, J., Price, M. A., Li, G. Y., Bar‐Eli, M., Salgia, R., Jagedeeswaran, R., Carlson, J. H., Ferrone, S., Turley, E. A., & McCarthy, J. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4626 · Cited by 106 · cited 1×
“In the case of melanoma, increased levels of melanoma-associated chondroitin sulfate proteoglycan (MCSP) are observed, which enhances integrin function, thereby activating Erk1/2 and stimulating cell growth and motility [40].”
BackgroundLi, F., ten Dam, G. B., Murugan, S., Yamada, S., Hashiguchi, T., Mizumoto, S., Oguri, K., Okayama, M., van Kuppevelt, T. H., & Sugahara, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806015200 · Cited by 105 · cited 1×
“A higher proportion of CS-E was found in the highly-metastatic LM660H11 lung carcinoma cell line, when compared to the P29 cell line with low metastatic potential, suggesting the role of CS-E in metastasis [43].”
BackgroundHeparin Mimetics: Their Therapeutic Potential
Mohamed, S., & Coombe, D. (2017) · Pharmaceuticals · doi:10.3390/ph10040078 · Cited by 99 · cited 2×
“To address the issues involved in the development of GAGs as therapeutics, multiple strategies have been developed to mimic GAGs through small molecules called GAG mimetics [92].”
BackgroundBarritault, D., Gilbert-Sirieix, M., Rice, K. L., Siñeriz, F., Papy-García, D., Baudouin, C., Desgranges, P., Zakine, G., Jl, S., & van Neck, J. W. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9744-5 · Cited by 90
Shojania, A. M., Tetreault, J., & Turnbull, G. J. (1988) · American Journal of Clinical Pathology · doi:10.1093/ajcp/89.1.19 · Cited by 89 · cited 1×
“Hence, the quality of heparin obtained depends on the environmental conditions and the diet each animal is exposed to and results in significant batch-to-batch variation [93].”
BackgroundKozlowski, E. O., Pavão, M. S. G., & Borsig, L. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04401.x · Cited by 86 · cited 1×
“Exogenous DS of a specific length is found to inhibit P-selectins in inflammatory mouse models [83].”
BackgroundSkandalis, S. S., Kletsas, D., Kyriakopoulou, D., Stavropoulos, M., & Theocharis, D. A. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.03.021 · Cited by 84 · cited 1×
“Changes to the CS chains of versican with enhanced expression of 6-O-sulfated and non-sulfated disaccharide units was observed in a malignant phenotype of pancreatic cancer [39].”
BackgroundPumphrey, C. Y., Theus, A. M., Li, S., Parrish, R. S., & Sanderson, R. D. (2002) · PubMed · Cited by 81
Carlson, E. C., Lin, M., Liu, C., Kao, W. W. ‐., Perez, V. L., & Pearlman, E. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705823200 · Cited by 81 · cited 1×
“In the cornea, KS proteoglycans are found to bind to chemokine CXCL1 and facilitate its migration into the stroma during inflammation [88].”
BackgroundChondroitin Sulfate as a Key Molecule in the Development of Atherosclerosis and Cancer Progression
Theocharis, A. D., Tsolakis, I. A., Tzanakakis, G. N., & Karamanos, N. K. (2006) · Advances in pharmacology · doi:10.1016/s1054-3589(05)53013-8 · Cited by 81 · cited 1×
“Structural alterations to CS chains, especially their sulfation pattern, is associated with cancer progression [41].”
BackgroundKosunen, A. S. T., Ropponen, K. M., Kellokoski, J. K., Pukkila, M. J., Virtaniemi, J. A., Valtonen, H., Kumpulainen, E., Johansson, R. T., Tammi, R., Tammi, M., et al. (2003) · Oral Oncology · doi:10.1016/j.oraloncology.2003.08.004 · Cited by 78 · cited 1×
“On the other hand, low levels of HA are associated with metastatic potential in squamous cell carcinoma [51] and melanoma [52].”
BackgroundBrito, A. S., Arimatéia, D. S., Souza, L. R., Lima, M. A., Santos, V. O., Medeiros, V. P., Ferreira, P. A., Silva, R. A., Ferreira, C. V., Justo, G. Z., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.09.020 · Cited by 77 · cited 1×
“Another non-anticoagulant heparin isolated from shrimp Litopenaeus vannamei has significantly reduced the influx of inflammatory cells to the site of injury in acute inflammation models [82].”
BackgroundInvolvement of chondroitin sulfate E in the liver tumor focal formation of murine osteosarcoma cells
Basappa, B., Murugan, S., Sugahara, K. N., LEE, C. M., ten Dam, G. B., Kuppevelt, T. H. V., Miyasaka, M., Yamada, S., & Sugahara, K. (2009) · Glycobiology · doi:10.1093/glycob/cwp041 · Cited by 75 · cited 1×
“It was also shown that overexpression of CS-E causes colonization of osteosarcoma cells in the liver [44].”
BackgroundKhachigian, L. M., & Parish, C. R. (2004) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2004.tb00127.x · Cited by 74 · cited 1×
“Phosphomannopentaose sulfate (PI-88; Figure 3A) is an HS mimetic obtained via sulfation of the phospho-mannan complex produced from yeast cultures [97].”
BackgroundChalkiadaki, G., Nikitovic, D., Berdiaki, A., Sifaki, M., Krasagakis, K., Katonis, P., Karamanos, N. K., & Tzanakakis, G. N. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.11.008 · Cited by 74 · cited 1×
“It was also shown that syndecan-4 expression promotes tumor adhesion and migration in melanoma cells [25].”
BackgroundYing, P., Shakibaei, M., Patankar, M. S., Clavijo, P., Beavis, R. C., Clark, G. F., & Frevert, U. (1997) · Experimental Parasitology · doi:10.1006/expr.1996.4134 · Cited by 73 · cited 3×
“Class of Binding Proteins Physiological Function Example Enzymes Coagulation Factor Xa [4] Enzyme inhibitors Coagulation, inflammation Antithrombin III [4] Cell adhesion proteins Cell adhesion,inflammation, metastasis Platelet/endothelial cell adhesion molecule-1 [5] Extracellular matrix (ECM) proteins Cell adhesion,…”
Lanzi, C., & Cassinelli, G. (2018) · Molecules · doi:10.3390/molecules23112915 · Cited by 71 · cited 1×
“It reached Phase III clinical trials for hepatocellular carcinoma, which was concluded after interim analysis due to the failure to reach the primary disease-free survival endpoint [98].”
BackgroundHeparin as an Inhibitor of Cancer Progression
Borsig, L. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)93014-7 · Cited by 71 · cited 1×
“For example, heparin, in addition to its anticoagulant properties, also possesses anti-cancer properties [58,59].”
BackgroundHSulf-1 Modulates FGF2- and Hypoxia-Mediated Migration and Invasion of Breast Cancer Cells
Khurana, A., Liu, P., Mellone, P., Lorenzon, L., Vincenzi, B., Datta, K., Yang, B., Linhardt, R. J., Lingle, W. L., CHIEN, J. R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3059 · Cited by 70 · cited 1×
“Downregulation of human sulfatase-1 (SULF1), a heparin-degrading endosulfatase, observed in breast cancer cells, is shown to increase cell migration and invasion [33].”
BackgroundPhase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia
Wun, T., Styles, L., DeCastro, L., Telen, M. J., Kuypers, F., Cheung, A., Kramer, W., Flanner, H., Rhee, S., Magnani, J. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101301 · Cited by 69 · cited 1×
“It was demonstrated to be safe in Phase I clinical trials [109], reduced the time to resolve vascular occlusive events in Phase II [110], and is currently in Phase III clinical trials.”
BackgroundHammond, E., Handley, P., Dredge, K. S., & Bytheway, I. (2013) · FEBS Open Bio · doi:10.1016/j.fob.2013.07.007 · Cited by 64
Nikitovic, D., Assouti, M., Sifaki, M., Katonis, P., Krasagakis, K., Karamanos, N. K., & Tzanakakis, G. N. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.019 · Cited by 63 · cited 1×
“HS has been shown to promote cell-cell and cell-ECM adhesion, inhibiting invasion and metastasis, and a decrease in the levels of HS, as seen in some cancers, resulted in the malignant cells being more invasive [7,20].”
BackgroundGomes, A. M., Kozlowski, E. O., Borsig, L., Teixeira, F. C. O. B., Vlodavsky, I., & Pavão, M. S. G. (2014) · Glycobiology · doi:10.1093/glycob/cwu119 · Cited by 60 · cited 1×
“A non-anticoagulant HS, isolated from the bivalve mollusk Nodipecten nodosus, has been shown to inhibit P-selectin-mediated events such as metastasis of Lewis lung carcinoma cells [63].”
BackgroundFreeman, C. G., Liu, L., Banwell, M. G., Brown, K. J., Bezos, A., Ferro, V., & Parish, C. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410769200 · Cited by 58 · cited 1×
“A library of small HS mimetics was developed by Parish and co-workers from sulfation of cyclitols [103].”
BackgroundFernández‐Vega, I., García‐Suárez, O., García, B., Crespo, A., Astudillo, A., & Quirós, L. M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1724-9 · Cited by 56 · cited 2×
“Changes in the expression levels of CS biosynthetic enzymes are also found in certain cancers [21,22].”
BackgroundInteraction of heparin with annexin V
Capila, I., VanderNoot, V. A., Mealy, T. R., Seaton, B. A., & Linhardt, R. J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00245-8 · Cited by 55 · cited 2×
“Extracellular matrix (ECM) proteins Cell adhesion, matrix organization Annexin V [6]”
BackgroundHeparanase Induces Signal Transducer and Activator of Transcription (STAT) Protein Phosphorylation
Cohen‐Kaplan, V., Jrbashyan, J., Yanir, Y., Naroditsky, I., Ben‐Izhak, O., Ilan, N., Doweck, I., & Vlodavsky, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271346 · Cited by 55 · cited 1×
“HPSE also enhances the phosphorylation of Src and epidermal growth factor receptor (EGFR), activating STAT3, which is associated with head and neck cancer progression [30].”
BackgroundCañas, N., Gorina, R., Planas, A. M., Vergés, J., Montell, E., García, A. G., & López, M. G. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.069 · Cited by 52 · cited 1×
“On the other hand, CS is found to inhibit inflammation in rat astrocytes by preventing NF-κB activation [84].”
BackgroundGriffin, K. L., Fischer, B. M., Kummarapurugu, A. B., Zheng, S., Kennedy, T. P., Rao, N. V., Foster, W. M., & Voynow, J. A. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0338rc · Cited by 51 · cited 1×
“One such example is 2-O,3-O-desulfated heparin (ODSH), which was shown to reduce airway inflammation by potently inhibiting human neutrophil elastase without any anticoagulant effects [81].”
BackgroundRole of glycosaminoglycans of biglycan in BMP-2 signaling
Miguez, P. A., Terajima, M., Nagaoka, H., Mochida, Y., & Yamauchi, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.022 · Cited by 47 · cited 4×
“Morphogens Cell specification, tissue differentiation, development BMP-2 [10]”
BackgroundInfluentialGlycosaminoglycan-lipoprotein interaction
Olsson, U., Östergren-Lundén, G., & Moses, J. (2001) · Glycoconjugate Journal · doi:10.1023/a:1021155518464 · Cited by 46
The influence of glycosaminoglycans on IL-8-mediated functions of neutrophils
Schlorke, D., Thomas, L., Samsonov, S. A., Huster, D., Arnhold, J., & Pichert, A. (2012) · Carbohydrate Research · doi:10.1016/j.carres.2012.02.025 · Cited by 46 · cited 5×
“Chemokines Chemotaxis, signaling inflam ation IL-8 [9]”
InfluentialSynthetic, Non-saccharide, Glycosaminoglycan Mimetics Selectively Target Colon Cancer Stem Cells
Patel, N. J., Karuturi, R., Al‐Horani, R. A., Baranwal, S., Patel, J., Desai, U. R., & Patel, B. B. (2014) · ACS Chemical Biology · doi:10.1021/cb500402f · Cited by 45 · cited 5×
“They developed a tandem, dual-screen strategy to screen selectively for molecules targeting CSCs over the population of bulk c ncer cells.”
BackgroundInfluentialBoothello, R. S., Patel, N. J., Sharon, C., Abdelfadiel, E. I., Morla, S., Brophy, D. F., Lippman, H. R., Desai, U. R., & Patel, B. B. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0104 · Cited by 44 · cited 1×
“2 also inhibited the growth of tumor in CSC induced xenografts in vivo [106].”
BackgroundSelf-citationHuman Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts
Peterson, S. M., Iskenderian, A., Cook, L., Romashko, A., Tobin, K., Jones, M. A., Norton, A. W., Gómez-Yafal, A., Heartlein, M. W., Concino, M. F., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-427 · Cited by 40 · cited 1×
“Human sulfatase-2 (SULF2), an HS 6-O-endosulfatase, was found to inhibit in vivo tumor growth in human breast cancer xenograft models [34].”
BackgroundHeparanase and cancer progression: New directions, new promises
Arvatz, G., Weissmann, M., Ilan, N., & Vlodavsky, I. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1171442 · Cited by 38
Patel, N. J., Sharon, C., Baranwal, S., Boothello, R. S., Desai, U. R., & Patel, B. B. (2016) · Oncotarget · doi:10.18632/oncotarget.12358 · Cited by 38 · cited 1×
“Desai and co-workers found that a particular non-anticoagulant hexasaccharide sequence of HS, called HS06, selectively inhibited cancer-stem-cell (CSC) self-renewal and induced apoptosis in several colorectal, breast, and pancreatic cell lines [65].”
BackgroundCarlson, E. C., Sun, Y., Auletta, J. J., Kao, W. W. ‐., Liu, C., Perez, V. L., & Pearlman, E. M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310134 · Cited by 38 · cited 1×
“The addition of low molecular weight KS resulted in the disruption of this KS-CXCL1 complex, leading to efflux of chemokines and resolution of inflammation [89].”
BackgroundLiu, Y., Yang, H., Otaka, K., Takatsuki, H., & Sakanishi, A. (2005) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2005.04.011 · Cited by 34 · cited 1×
“Exogenous CS-A has been shown to be effective in decreasing monocyte migration, thereby preventing angiogenesis in vitro [68].”
BackgroundGangji, R. N., Sankaranarayanan, N. V., Elste, J., Al‐Horani, R. A., Afosah, D. K., Joshi, R., Tiwari, V., & Desai, U. R. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00364 · Cited by 33 · cited 1×
“Viral proteins Viral infections Glycoprotein D [13]”
Gao, C., Fujinawa, R., Yoshida, T., Ueno, M., Ota, F., Kizuka, Y., Hirayama, T., Korekane, H., Kitazume, S., Maeno, T., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00151.2016 · Cited by 33 · cited 1×
“In a study by Taniguchi and coworkers, a KS disaccharide, [SO3−-6]Galβ1-4[SO3−-6]GlcNAc, prevented neutrophil-mediated inflammation and progression of emphysema in murine models, indicating its potential use for the treatment of inflammation in chronic obstructive pulmonary disease [90,91].”
BackgroundNonaka, M., Bao, X., Matsumura, F., Götze, S., Kandasamy, J., Kononov, A., Broide, D. H., Nakayama, J., Seeberger, P. H., & Fukuda, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319870111 · Cited by 31
The Promise of Sulfated Synthetic Small Molecules as Modulators of Glycosaminoglycan Function
Desai, U. R. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.117 · Cited by 31 · cited 1×
“They are usually completely synthetic and homogenous molecules and hence are expected to have increased selectivity and fewer adverse effects [96].”
BackgroundChemistry and Biology of Glycosaminoglycans in Blood Coagulation
Barbucci, R., Magnani, A., Lamponi, S., & Albanese, A. (1996) · Polymers for Advanced Technologies · doi:10.1002/(sici)1099-1581(199608)7:8<675::aid-pat609>3.0.co;2-u · Cited by 29 · cited 3×
“Class of Binding Proteins Physiological Function Example Enzymes Coagulation Factor Xa [4] Enzyme inhibitors Coagulation, inflammation Antithrombin III [4] Cell adhesion proteins Cell adhesion,inflammation, metastasis Platelet/endothelial cell adhesion molecule-1 [5] Extracellular matrix (ECM) proteins Cell adhesion,…”
Hedlund, K. D., Coyne, D., Sanford, D. M., & Huddelson, J. (2012) · Perfusion · doi:10.1177/0267659112462274 · Cited by 25
Craciun, I., Fenner, A. M., & Kerns, R. J. (2016) · Glycobiology · doi:10.1093/glycob/cww011 · Cited by 25
Crespo, A., García‐Suárez, O., Fernández‐Vega, I., Solís-Hernández, M. P., García, B., Castañón, S., & Quirós, L. M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4597-x · Cited by 23 · cited 4×
“Changes in the expression levels of CS biosynthetic enzymes are also found in certain cancers [21,22].”
BackgroundInfluentialPolymeric fluorescent heparin as one-step FRET substrate of human heparanase
Sistla, J. C., Morla, S., Alabbas, A. B., Kalathur, R., Sharon, C., Patel, B. B., & Desai, U. R. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.10.071 · Cited by 23
Self-citationKühnast, B., Hadri, A. E., Boisgard, R., Hinnen, F., Richard, S., Caravano, A., Nancy-Portebois, V., Petitou, M., Tavitian, B., & Dollé, F. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob02513c · Cited by 23 · cited 1×
“Dollé and coworkers synthesized an octasaccharide heparin mimetic that interfered with the process of angiogenesis and metastasis [102].”
BackgroundThe antineoplastic effect of low-molecular-weight heparins – a literature review
Bochenek, J., Püsküllüoğlu, M., & Krzemieniecki, K. (2013) · Współczesna Onkologia · doi:10.5114/wo.2013.33766 · Cited by 15 · cited 1×
“For example, heparin, in addition to its anticoagulant properties, also possesses anti-cancer properties [58,59].”
BackgroundLim, T. C., Cai, S., Huber, R. G., Bond, P. J., Chia, P. X. S., Khou, S. L., Gao, S., Lee, S. S., & Lee, S.-G. (2018) · Chemical Science · doi:10.1039/c8sc02303d · Cited by 12 · cited 2×
“turnability, and helicity, as shown through molecular dynamics simulations [107].”
BackgroundTruong, T. M., Li, H., Dhapare, S., Desai, U. R., Voelkel, N. F., & Sakagami, M. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.06.007 · Cited by 12
Heparin-derived supersulfated disaccharide inhibits allergic airway responses in sheep
Ahmed, T. A., Smith, G. J., & Abraham, W. M. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.12.001 · Cited by 5
Cited by
Kojima, H., Kushige, H., Yagi, H., Nishijima, T., Moritoki, N., Nagoshi, N., Nakano, Y., Tanaka, M., Hori, S., Hasegawa, Y., et al. (2023) · Cell Transplantation · doi:10.1177/09636897231170437 · Cited by 12
Metadata
- Authors
- Morla, S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-04-22
- Volume
- 20
- Issue
- 8
- Pages
- 1963
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2937369800
- Cited by
- 214
- References
- 103
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.